Search the webpage

Created by Simon Kaja on   September 7, 2018   in category: News

  • The XXXIII Biennial Meeting of the International Society of Eye Research takes place this year from September 9-13th in Belfast, Northern Ireland, UK. 
  • Dr Jenni J. Hakkarainen – Acting Chief Operating Officer of Experimentica Ltd. will present an oral presentation entitled: Protection by a metalloporphyrin superoxide dismutase mimetic against signs of dry-eye disease
  • Dr Simon Kaja – Chief Scientific Officer of Experimentica Ltd. will chair a session and present on cellular mechanisms of reactive astrocytosis and opportunities for glioprotection

[Kuopio, Finland and Chicago, USA – September 7th, 2018] – Experimentica Ltd. announces its participation in the scientific sessions at the biennial meeting of the International Society of Eye Research. The event takes place September 9th – 13th at the Belfast Waterfront Meeting Centre 2 Lanyon Place, Belfast, BT1 3WH.

Through its participation in this year’s ISER meeting Experimentica Ltd. is proud to be able to showcase its scientific know-how as well as its world-class researchers through its presentations and abstracts. It is our hope that attendees will feel free to make contact with them in order to discuss their scientific research as well as the Experimentica Ltd. product offering. Experimentica Ltd. extends a warm welcome to all attendees at this years meeting.

About Experimentica Ltd.: Experimentica Ltd. is a global contract research organization (CRO) that specializes in preclinical models of ophthalmology and neurology. The world class scientists and technicians apply a comprehensive set of skills on various in vitro, ex vivo and in vivo modelling platforms. With proprietal laboratories in Kuopio, Finland, and representation globally, Experimentica Ltd. delivers the highest quality science in ophthalmology and neurological models.



New Board of Directors announced

Experimentica Ltd., a global contract research organization that specializes in preclinical models for ophthalmic diseases, is pleased to announce its ... Read More

New insights to the supporting mechanism of fluid management in the neural retina

Angiopoietin-4 was identified as the first growth factor having a venous-specific function in the mouse retina, according to a publication ... Read More

Experimentica Ltd. opens a new R&D site in Lithuania

The investment totaling €1.6 million was supported, in part, by a competitive award “Smart FDI” (project no. 01.2.1-LVPA-T-848-01-005) under the ... Read More

Subscribe to Our Newsletter!

We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!